← Back to Search
Corticosteroid
Brepocitinib for Uveitis (CLARITY Trial)
New York, NY
Phase 3
Recruiting
Research Sponsored by Priovant Therapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult subjects aged 18-74 years
Active uveitic disease in at least 1 eye
Must not have
History of thrombosis and cardiovascular disease within the last 12 months
Active or recent infections
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Pivotal Trial
Summary
This trial aims to find out if brepocitinib is safe and effective in reducing the need for corticosteroids in people with a specific type of eye inflammation called non-infectious u
See full description
Who is the study for?
Adults aged 18-74 with active, non-infectious uveitis (intermediate, posterior, or panuveitis), not caused by an infection. Participants must have certain levels of eye inflammation or vitreous haze and weigh over 40 kg with a BMI under 40 kg/m2.Check my eligibility
What is being tested?
The trial is testing the safety and effectiveness of Brepocitinib in reducing eye inflammation compared to a placebo. It also looks at whether Brepocitinib can help reduce the need for corticosteroids used to treat uveitis.See study design
What are the potential side effects?
Possible side effects of Brepocitinib may include reactions at the medication intake site, increased risk of infections due to immune system suppression, headaches, nausea, and potential liver issues.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 74 years old.
show original
Select...
I have active inflammation in at least one of my eyes.
show original
Select...
I weigh more than 40 kg and my BMI is less than 40.
show original
Select...
I have been diagnosed with a type of eye inflammation that is not caused by an infection.
show original
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have not had a blood clot or heart disease in the past year.
show original
Select...
I currently have, or recently had, an infection.
show original
Select...
I have or might have an eye infection causing inflammation.
show original
Select...
I have a history of disorders related to lymphocyte proliferation.
show original
Select...
I have a history of cancer.
show original
Select...
I am at high risk for shingles reactivation.
show original
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Arm 1Experimental Treatment1 Intervention
Group II: Arm 2Placebo Group1 Intervention
Find a Location
Closest Location:Clinical Trial Site· Cleveland, OH· 127 miles
Who is running the clinical trial?
Priovant Therapeutics, Inc.Lead Sponsor
3 Previous Clinical Trials
272 Total Patients Enrolled
1 Trials studying Uveitis
26 Patients Enrolled for Uveitis